Peters DT, Koenig K, Ivanova A, He J, Roboz GJ, Borate U, Gonzalez-Lugo J, Lin T, Powell B, Curran E, Hochman M, Reed D, Nichols A, Higgins L, McKinney A, Mims A, Carson W, Dees EC, Little RF, Streicher H, Hourigan C, Luznik L, Gojo I, Zeidner JF. Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related. haematol [Internet]. 2020Sep.10 [cited 2026Sep.26];. Available from: https://haematologica.org/article/view/14447